Tirzepatide/Cyanocobalamin 10mg/500mcg/ml 2mL

Tirzepatide / Cyanocobalamin 10 mg / 500 mcg per mL – 2 mL Vial is a compounded injectable formulation combining a dual incretin receptor agonist with vitamin B12 to support glycemic control, weight management, and metabolic function. Tirzepatide 10 mg/mL – Tirzepatide is a dual GLP-1 and GIP receptor agonist that enhances glucose-dependent insulin secretion, reduces glucagon output, delays gastric emptying, and promotes satiety. These combined effects contribute to significant reductions in blood glucose and body weight. A 2 mL vial contains a total of 20 mg of tirzepatide. It is FDA-approved as Mounjaro for type 2 diabetes. Cyanocobalamin (Vitamin B12) 500 mcg/mL – Vitamin B12 supports red blood cell production, neurologic function, and energy metabolism. The 2 mL vial provides a total of 1 mg of B12, which may complement metabolic support and help reduce fatigue. This sterile solution is intended for subcutaneous injection in clinical or research settings. Tirzepatide has demonstrated strong efficacy in improving glycemic control and promoting weight loss in clinical trials. Clinical outcomes and metabolic effects of tirzepatide: https://pubmed.ncbi.nlm.nih.gov/33657290/ Mechanism of GLP-1/GIP receptor agonists: https://pubmed.ncbi.nlm.nih.gov/34534432/